989 top medical experts on Rhabdomyosarcoma across 42 countries and 39 U.S. states, including 933 MDs (Physicians). This is based on an objective analysis of their Scientific Publications, Clinical Trials, Medicare, and NIH Grants.

  1. Rhabdomyosarcoma: A malignant solid tumor arising from mesenchymal tissues which normally differentiate to form striated muscle. It can occur in a wide variety of sites. It is divided into four distinct types: pleomorphic, predominantly in male adults; alveolar (rhabdomyosarcoma, alveolar), mainly in adolescents and young adults; embryonal (rhabdomyosarcoma, embryonal), predominantly in infants and children; and botryoidal, also in young children. It is one of the most frequently occurring soft tissue sarcomas and the most common in children under 15. (From Dorland, 27th ed; Holland et al., Cancer Medicine, 3d ed, p2186; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, pp1647-9)
  2. Clinical guidelines are the recommended starting point to understand initial steps and current protocols in any disease or procedure:
  3. Broader Categories (#Experts): Myosarcoma (105) and Narrower Categories: Alveolar Rhabdomyosarcoma (1,648), Embryonal Rhabdomyosarcoma (2,156).
  4. Clinical Trials ClinicalTrials.gov : at least 196 including 29 Active, 87 Completed, 48 Recruiting


  

        

                    


    Computing Expert Listing ...

);